MedTrace Logo

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)

NCT01767298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-01-14

No results posted yet for this study

Summary

This study was conducted to compare the rate and extent of absorption of valsartan and hydrochlorothiazide. To maximize the possibility of finding drug-drug interactions, the dose of valsartan and hydrochlorothiazide was doubled (320 mg of VAL and 25 mg of HCT).

Conditions

  • Healthy Normotensive Participants

Interventions

DRUG

Valsartan/Hydrochlorothiazide

Co-administration or fixed dose combination

DRUG

Valsartan

Valsartan alone

DRUG

Hydrochlorothiazide

Hydrochlorothiazide alone

Sponsors & Collaborators

  • Damanhour University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01767298 on ClinicalTrials.gov